Navegando por Assunto "Sistema cardiovascular"

Agora exibindo 1 - 2 de 2

Avaliação do risco cardiovascular em pacientes com lúpus eritematoso sistêmico atendidos no CEMEC
(Centro Universitário do Estado do Pará, 2019-05-20) Borborema, Augusto Lopes Pereira de; Santos, Felipy Chaves dos; Cristino, Sônia Conde; Rodrigues, Fabíola Brasil Barbosa; http://lattes.cnpq.br/2425897539868497; http://lattes.cnpq.br/7942684022038270; Ohashi, Claudia Barros; http://lattes.cnpq.br/0889116450004563; Costa, Alberto Freire Sampaio; http://lattes.cnpq.br/8830564785408868
Introduction: Systemic Lupus Erythematosus - SLE is a disease of autoimmune origin with a large number of clinical and laboratory manifestations. The pathophysiological nature of lupus involves both chronic and atherosclerotic inflammatory processes, which gives pathology an important role in the genesis of changes related to the cardiovascular system. In this context, it is essential to use the Framingham score in an attempt to estimate the cardiovascular risk in lupus patients and the interaction with traditional and non-traditional risk factors. Objectives: General: To evaluate cardiovascular risk in patients with Systemic Lupus Erythematosus in follow-up at CEMEC. Specific: To establish the prevalence of cardiovascular risk factors in SLE patients followed at CEMEC; 3) To characterize the epidemiological profile of patients with SLE treated at CEMEC; 4) Describe the characteristics of patients with SLE treated at CEMEC and relate it to cardiovascular risk. Methods: A research protocol was developed in which patient information is fundamental to the research: age, sex, time of illness, smoking, systolic blood pressure, total cholesterol, HDL, diabetes, medications in use and type of SLE. The search for data was based on the analysis of medical records of patients with SLE treated at CEMEC. Subsequently, these data were applied to the Framingham score. Results: It was observed that of the 68 patients who met the inclusion and exclusion criteria, 88.2% were female, 33.8% were in the age group below 30 years of age and 44.1% (n = 30) present a disease time between 6 and 10 years. Cutaneous involvement was the most prevalent, with 88.2% of cases. Regarding cardiovascular risk, 94.1% of the patients presented low risk, 1.5% medium risk and 4.4% high risk. The Immunossupressor / Immunomodulator class is part of the treatment of 92.6% of the patients. Conclusion: The study concludes that the Framingham score was not able to correctly identify cardiovascular risk in SLE patients.
Os desafios na adesão às metas da diretriz nacional de atendimento a pacientes com síndrome coronariana aguda em um centro especializado em cardiologia no Pará
(Centro Universitário do Estado do Pará, 2021) Brandão, Ana Luiza Lelis; Domingues, Gabriela de Pinho; Pereira, Paulo Henrique Nunes; Zaninotto, Christielaine Venzel; http://lattes.cnpq.br/6371342553422340; http://lattes.cnpq.br/5351191172079560
Acute Coronary Syndrome generates excessive costs in the national health system, in addition to representing a disease of high incidence and great impact in terms of morbidity and mortality. The identification and understanding of extra and in-hospital factors that influence the prognosis are extremely important to improve the care of patients with Acute Coronary Syndrome (ACS). This project aimed to evaluate the time between the onset of symptoms, the time to perform the in-hospital diagnostic and therapeutic measures and the prognosis of patients with acute coronary syndrome in a reference hospital in cardiology in Belém-PA and compare with the established goals by the V Guideline of the Brazilian Society of Cardiology on the Treatment of Acute Myocardial Infarction with ST-Segment Elevation. Data from the Good Practices in Cardiology Program, in which the Hospital de Clinicas Gaspar Vianna participates, from 2017 to 2020 are used. The data were represented in Microsoft Excel tables and analyzed using the Biostat 5.0 program. Results: Men were more affected with ACS (74%), the most prevalent age was 50 to 69 years (62%). Most patients came from UPAS (Emergency Care Units) (39%), followed by their own residence (22%) and transferred from another hospital (18%). The time to seek care for the majority was between 4 and 8 hours (36.9%), the time to perform the electrocardiogram was less than 10 minutes in 54.2% of the patients and the door-to-balloon time was less than 90 minutes in 51.8%, between 90 and 120 minutes in 23.4% and greater than 120 minutes in 24%. Correlating the ejection fraction (EF) with the time until arrival at the service, it was found that regardless of the final EF, the search for the health service took place between 4 to 8 hours. It was also found that patients with severely decreased ejection fraction (<30%) sought, for the most part (60%), more than 8 hours for care. In the association between time to angioplasty and ejection fraction, 52.9% of patients with EF > 40% underwent catheterization within 90 minutes. The percentage of patients between 90 and 120 minutes and greater than 120 minutes was, respectively, 28.8% and 24.2%. It is concluded that several factors are interconnected in order to reach the best times until seeking care, establishing the diagnosis and starting therapy, resulting in benefits for myocardial viability in patients with ACS, according to the efficiency of these factors. Thus, compliance with the goals established by national guidelines is essential for the pursuit of excellence in care.